Trading window closed from 1 Oct 2026 ahead of Q2 results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹39.29

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+0.8% vs market

Pharmaceuticals peers, median of 172sector-1.5%+0.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8-1.6+0.8-1.5+0.7

Next day

-7.7-0.6-7.2-1.0-6.8

-8.4-0.8-7.5-1.9-6.5

-8.4-2.1-6.3-2.4-6.0

-12.2-2.1-10.1-3.2-8.9

-5.9-0.8-5.1-2.4-3.5

-9.9-3.8-6.1-4.2-5.7

15d

-10.9-6.9-4.0-7.8-3.1

+8.9pendingpending-6.6+15.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Terce Laboratories has closed its trading window for designated persons and their immediate relatives from 1 October 2026 until 48 hours after the declaration of Q2 FY26 unaudited financial results (quarter ending 30 September 2026). This is a routine SEBI compliance step under PIT Regulations to prevent insider trading ahead of results. The board meeting date to approve Q2 results will be announced separately.

Likely market impact

Routine compliance. Designated persons cannot trade shares until 48 hours after Q2 results. Investors should watch for the results date announcement.